These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 8212007)

  • 21. Striatal extracellular dopamine levels and behavioural reversal in MPTP-lesioned mice.
    Kirchhoff J; Mørk A; Brennum LT; Sager TN
    Neuroreport; 2009 Mar; 20(5):482-6. PubMed ID: 19262413
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of noradrenergic lesions on MPTP/MPP+ kinetics and MPTP-induced nigrostriatal dopamine depletions.
    Fornai F; Alessandrì MG; Torracca MT; Bassi L; Corsini GU
    J Pharmacol Exp Ther; 1997 Oct; 283(1):100-7. PubMed ID: 9336313
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one), a radical scavenger, prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in the substantia nigra but not the striatum.
    Kawasaki T; Ishihara K; Ago Y; Baba A; Matsuda T
    J Pharmacol Exp Ther; 2007 Jul; 322(1):274-81. PubMed ID: 17429058
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Consequences of manganese administration for striatal dopamine and motor behavior in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-exposed C57BL/6 mice.
    Dodd CA; Bloomquist JR; Klein BG
    Hum Exp Toxicol; 2013 Aug; 32(8):865-80. PubMed ID: 23263854
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in the rat: characterization and age-dependent effects.
    Jarvis MF; Wagner GC
    Synapse; 1990; 5(2):104-12. PubMed ID: 2309157
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-lasting reactive changes observed in microglia in the striatal and substantia nigral of mice after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Yasuda Y; Shinagawa R; Yamada M; Mori T; Tateishi N; Fujita S
    Brain Res; 2007 Mar; 1138():196-202. PubMed ID: 17275793
    [TBL] [Abstract][Full Text] [Related]  

  • 27. H MRS identifies lactate rise in the striatum of MPTP-treated C57BL/6 mice.
    Koga K; Mori A; Ohashi S; Kurihara N; Kitagawa H; Ishikawa M; Mitsumoto Y; Nakai M
    Eur J Neurosci; 2006 Feb; 23(4):1077-81. PubMed ID: 16519673
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Age-related severity of dopaminergic neurodegeneration to MPTP neurotoxicity causes motor dysfunction in C57BL/6 mice.
    Ohashi S; Mori A; Kurihara N; Mitsumoto Y; Nakai M
    Neurosci Lett; 2006 Jun; 401(1-2):183-7. PubMed ID: 16581184
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MK-801 temporarily prevents MPTP-induced acute dopamine depletion and MPP+ elimination in the mouse striatum.
    Chan P; Langston JW; Di Monte DA
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1515-20. PubMed ID: 8263813
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activated microglia affect the nigro-striatal dopamine neurons differently in neonatal and aged mice treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Sawada H; Hishida R; Hirata Y; Ono K; Suzuki H; Muramatsu S; Nakano I; Nagatsu T; Sawada M
    J Neurosci Res; 2007 Jun; 85(8):1752-61. PubMed ID: 17469135
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyclooxygenases mRNA and protein expression in striata in the experimental mouse model of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration to mouse.
    Przybyłkowski A; Kurkowska-Jastrzebska I; Joniec I; Ciesielska A; Członkowska A; Członkowski A
    Brain Res; 2004 Sep; 1019(1-2):144-51. PubMed ID: 15306248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of levodopa on striatal monoamines in mice with levodopa-induced hyperactivity.
    Nicholas AP; Buck K; Ferger B
    Neurosci Lett; 2008 Oct; 443(3):204-8. PubMed ID: 18657593
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ethylenebisdithiocarbamate enhances MPTP-induced striatal dopamine depletion in mice.
    McGrew DM; Irwin I; Langston JW
    Neurotoxicology; 2000 Jun; 21(3):309-12. PubMed ID: 10894120
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuroprotective mechanism of modafinil on Parkinson disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Xiao YL; Fu JM; Dong Z; Yang JQ; Zeng FX; Zhu LX; He BC
    Acta Pharmacol Sin; 2004 Mar; 25(3):301-5. PubMed ID: 15000882
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuroprotective effects of echinacoside in the mouse MPTP model of Parkinson's disease.
    Geng X; Tian X; Tu P; Pu X
    Eur J Pharmacol; 2007 Jun; 564(1-3):66-74. PubMed ID: 17359968
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Behavior, neurotransmitters and inflammation in three regimens of the MPTP mouse model of Parkinson's disease.
    Luchtman DW; Shao D; Song C
    Physiol Behav; 2009 Aug; 98(1-2):130-8. PubMed ID: 19410592
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of manganese exposure on MPTP neurotoxicities.
    Baek SY; Lee MJ; Jung HS; Kim HJ; Lee CR; Yoo C; Lee JH; Lee H; Yoon CS; Kim YH; Park J; Kim JW; Jeon BS; Kim Y
    Neurotoxicology; 2003 Aug; 24(4-5):657-65. PubMed ID: 12900079
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of estrogen receptors in neuroprotection by estradiol against MPTP toxicity.
    Morissette M; Jourdain S; Al Sweidi S; Menniti FS; Ramirez AD; Di Paolo T
    Neuropharmacology; 2007 Jun; 52(7):1509-20. PubMed ID: 17420033
    [TBL] [Abstract][Full Text] [Related]  

  • 39. l-dopa-induced reversal in striatal glutamate following partial depletion of nigrostriatal dopamine with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Holmer HK; Keyghobadi M; Moore C; Meshul CK
    Neuroscience; 2005; 136(1):333-41. PubMed ID: 16198485
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interferon-gamma deficiency modifies the motor and co-morbid behavioral pathology and neurochemical changes provoked by the pesticide paraquat.
    Litteljohn D; Mangano E; Shukla N; Hayley S
    Neuroscience; 2009 Dec; 164(4):1894-906. PubMed ID: 19782123
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.